The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?-Reference-Cited by-同舟云学术

The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?

Published:2016-03-03 Issue:4 Volume:16 Page:255-266
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Dézsi Csaba András

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40256-016-0165-4.pdf

Reference123 articles.

1. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

2. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;2013(31):1281–357.

3. Rosendorff C, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens. 2015;9(6):453–98.

4. Li Robert. Cardiovascular diseases: from molecular pharmacology to evidence-based therapeutics. Hoboken: Wiley.; 2015.

5. Negro R. Endothelial effects of antihypertensive treatment: focus on irbesartan. Vasc Health Risk Manag. 2008;4(1):89–101.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies;Cells;2024-09-01

2. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

3. Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study;Indian Heart Journal;2024-05

4. Renin and renin blockade have no role in complement activity;Kidney International;2024-02

5. Medicinal (Radio)Chemistry: Building Radiopharmaceuticals for the Future;Current Medicinal Chemistry;2023-08-18